What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
Zhao H, Cai H, Wang C, et al.
Am J Hematol · 2019
Key Findings
- ●Compared ASCT (n=165), MDex (n=79), LDex (n=103) as first-line therapy
- ●ASCT achieved highest hematologic CR (49.7%)
- ●Neurological remission similar across groups (~93%)
- ●3-year PFS 80.5%, 3-year OS 90.8% overall
Referenced in (1 disease)
Validation history
Full log →- passsource metadataJun 1, 2026, 04:40 PMby pubmed-api
Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).
tools: pubmed.esummary, crossref.works
ID: pmid-30700844DOI: 10.1038/s41375-019-0391-2PMID: 30700844